United States · Series A startup

Who invested in Helicore Biopharma

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$65Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $65MJan 2025
Investors
4
See who backed them

The rounds

  1. Jan 2025

Founders and team

From Helicore Biopharma's own website: 6 on the team.

  • Peter DiLauraChief Executive Officer and Board Director
  • Kalpesh BiyaniVP, Drug Product
  • Carlo RizzutoBoard Director
  • Dev. CandidateLead Optimization
  • Dina ChayaBoard Director
  • Jing LiangBoard Director

Everyone who backed them

OrbiMedPrivate equity1round
Versant VenturesVC firm1round
Longitude CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Helicore Biopharma

Who invested in Helicore Biopharma?

Helicore Biopharma's investors include OrbiMed, Wellington Management, Versant Ventures and Longitude Capital.

How much has Helicore Biopharma raised?

Helicore Biopharma has raised $65M across 1 round since 2025.

When did Helicore Biopharma last raise?

Helicore Biopharma's most recent round was a Series A of $65M in Jan 2025.

What was Helicore Biopharma's biggest round?

Its most recent round, $65M in Jan 2025, is also its largest on record.

Who backed Helicore Biopharma first?

Helicore Biopharma's first round on record, in Jan 2025, was backed by OrbiMed, Wellington Management and Versant Ventures and 1 others.

What stage is Helicore Biopharma at?

Helicore Biopharma's latest named round is a Series A, in Jan 2025.

Where is Helicore Biopharma based?

Helicore Biopharma is based in the United States.

Companies like Helicore Biopharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.